Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 51655-744

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 51655-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of pantoprazole shown with its molecular components including fluorine, sodium ion, methoxy groups, and water of hydration (1.5 H2O). The structure depicts the key functional groups characteristic of pantoprazole sodium.*
FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Label (51655 744 52 Rev A 07 21 Nhc)

Label (51655 744 52   Rev A 07 21 Nhc)
Label for Pantoprazole Sodium Delayed-Release Tablets USP 20 mg, oral dosage form, containing 30 tablets. The label indicates storage recommendations (20°-25°C) and cautions such as prescription-only status and instructions to keep out of reach of children. The labeler is Northwind Health Company, LLC, with NDC 51655-744-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.